UPB CJC/IPA 5MG/5MG without DAC
$79.99 Original price was: $79.99.$69.99Current price is: $69.99.
UPB CJC/IPA 5mg/5mg without DAC is a lyophilized research blend labeled with 5 mg of CJC-1295 (No DAC) and 5 mg of Ipamorelin. The accompanying Kovera Labs Certificate of Analysis documents blend identification, purity, and measured component content.
- Labeled quantity: 5 mg CJC-1295 (No DAC) + 5 mg Ipamorelin
- Total labeled content: 10 mg
- Reported average blend purity: 99.300%
- Form: Lyophilized powder
- Batch: 11060-003
Research Use Only. Not for human or veterinary use, consumption, or administration.
404 in stock
UPB CJC/IPA 5mg/5mg Without DAC — Research Blend
UPB CJC/IPA 5mg/5mg without DAC combines CJC-1295 (No DAC) and Ipamorelin in a lyophilized powder format for laboratory, analytical, and scientific research.
The product is labeled with 5 mg of each component, totaling 10 mg. Kovera Labs report KVR-2026-89EBEC provides analytical documentation for batch 11060-003, including blend identification, purity, and component content measurements.
Blend Composition
- CJC-1295 (No DAC): 5 mg labeled quantity
- Ipamorelin: 5 mg labeled quantity
- Combined labeled quantity: 10 mg
The certificate identifies the blend by LC-MS as CJC-1295 (No DAC)/Ipamorelin. These component names follow the laboratory report.
Purity
The downloadable Certificate of Analysis reports 99.300% average blend purity. Its batch conformity section lists:
- Vial 1: 99.323%
- Vial 2: 99.413%
- Vial 3: 99.164%
The chromatogram method is listed as RP-HPLC with a C18 column and DAD detection at 214 nm. Blend purity should not be presented as a separate purity percentage for each component.
Form
Lyophilized powder. This form is recorded in the certificate’s sample information.
Quantity
Total labeled quantity: 10 mg, comprising 5 mg of each component.
Reported average blend net content: 11.26 mg. Individual vial results are 11.26 mg, 11.48 mg, and 11.04 mg.
The blend component analysis lists:
- CJC-1295 (No DAC): 5.58 mg measured
- Ipamorelin: 5.68 mg measured
These are reported analytical measurements for the submitted samples. They do not guarantee identical content in every vial.
Batch / Lot Number
11060-003. Match this batch number with the supplied product label before using the certificate as its analytical reference.
Certificate of Analysis
- Testing laboratory: Kovera Labs
- Client: Ultra Pure Bioscience
- Product: CJC-1295 (No DAC)/Ipamorelin
- Certification date: May 27, 2026
- Report number: KVR-2026-89EBEC
- Access code: JWEJ224
- Batch: 11060-003
View and verify the CJC/IPA Certificate of Analysis for the complete report.
Additional Screening Results
Endotoxin screen: The certificate reports Pass against a listed reference limit of ≤0.5 EU/mL.
Microbial screen: The certificate reports No Growth under its Microbial Sterility Screen entry. This is a reported screening result for the tested sample, not a guarantee covering every vial.
Heavy metal screening: Arsenic, cadmium, lead, and mercury are each reported as Negative. The main certificate does not provide numerical concentrations or detection limits for these results.
Handling & Storage
The downloadable certificate does not specify storage temperatures or conditions after preparation. Obtain the manufacturer’s product-specific handling, storage, and shelf-life instructions before laboratory use.
Research Use Only
This product is not supplied as an FDA-approved medication. It is intended strictly for laboratory, analytical, and scientific research purposes. It is not intended for human or veterinary use, consumption, administration, diagnosis, prevention, or therapeutic application.
Frequently Asked Questions About CJC/IPA Without DAC
What does CJC/IPA 5mg/5mg mean?
It identifies a blend labeled with 5 mg of CJC-1295 (No DAC) and 5 mg of Ipamorelin, totaling 10 mg.
Does the certificate identify the CJC component as without DAC?
Yes. The sample information and LC-MS blend identification both specify CJC-1295 (No DAC)/Ipamorelin.
What purity does the COA report?
The downloadable report lists average blend purity as 99.300%. The three individual vial results range from 99.164% to 99.413%.
Is the blend supplied as powder or liquid?
The certificate identifies the form as lyophilized powder.
How much of each component was measured?
The component analysis lists 5.58 mg of CJC-1295 (No DAC) and 5.68 mg of Ipamorelin. These results are distinct from the labeled 5 mg quantity for each component.
How can I verify the certificate?
Open the Kovera verification link and check report KVR-2026-89EBEC, access code JWEJ224, and batch 11060-003 against your product documentation.
Certificate of Analysis & Verification
- Copy the certificate code below.
- Click the verification button.
- Paste the certificate code on the verification website.
- Submit the code to view and verify the official certificate result.
KVR-2026-89EBEC
